Violette M. Shelia's Insider Trades & SAST Disclosures
Violette M. Shelia's most recent trade in Q32 Bio Inc. was a trade of 56,413 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 24, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Violette M. Shelia.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Q32 Bio Inc. | Violette M. Shelia | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2025 | 56,413 | 56,413 | - | - | Stock Option (Right to Buy) | |
| Q32 Bio Inc. | Violette M. Shelia | Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Feb 2025 | 56,413 | 0 | - | - | Stock Option (Right to Buy) | |
| Q32 Bio Inc. | Shelia Violette M. | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2025 | 37,500 | 61,374 | - | 0 | Common Stock | |
| Q32 Bio Inc. | Shelia Violette M. | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2025 | 32,891 | 32,891 | - | - | Stock Option (Right to Buy) | |
| Q32 Bio Inc. | Violette Shelia M. | Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Feb 2025 | 32,891 | 0 | - | - | Stock Option (Right to Buy) | |
| Q32 Bio Inc. | M. Shelia Violette | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2025 | 17,506 | 17,506 | - | - | Stock Option (Right to Buy) | |
| Q32 Bio Inc. | Shelia M. Violette | Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Feb 2025 | 17,506 | 0 | - | - | Stock Option (Right to Buy) | |
| Q32 Bio Inc. | Violette M. Shelia | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2025 | 13,305 | 13,305 | - | - | Stock Option (Right to Buy) | |
| Q32 Bio Inc. | M. Shelia Violette | Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 24 Feb 2025 | 13,305 | 0 | - | - | Stock Option (Right to Buy) | |
| Q32 Bio Inc. | Shelia Violette M. | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Oct 2024 | 6,000 | 32,891 | - | - | Stock Option (Right to Buy) | |
| Q32 Bio Inc. | Violette Shelia M. | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.29 per share. | 11 Oct 2024 | 6,000 | 23,874 | - | 7.3 | 43,740 | Common Stock |
| Q32 Bio Inc. | Violette Shelia M. | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.12 per share. | 11 Oct 2024 | 4,574 | 17,874 | - | 3.1 | 14,271 | Common Stock |
| Q32 Bio Inc. | M. Shelia Violette | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Oct 2024 | 4,361 | 0 | - | - | Stock Option (Right to Buy) | |
| Q32 Bio Inc. | Shelia M. Violette | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Oct 2024 | 213 | 0 | - | - | Stock Option (Right to Buy) | |
| Q32 Bio Inc. | Shelia M. Violette | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.12 per share. | 08 Oct 2024 | 13,300 | 13,300 | - | 3.1 | 41,496 | Common Stock |
| Q32 Bio Inc. | Shelia M. Violette | Chief Scientific Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Oct 2024 | 13,300 | 213 | - | - | Stock Option (Right to Buy) | |
| Q32 Bio Inc. | Shelia M. Violette | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2024 | 56,413 | 56,413 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges